Screening of aptamers specific to colorectal cancer cells and stem cells by utilizing On-chip Cell-SELEX

Lien Yu Hung, Chih Hung Wang, Yu Jui Che, Chien Yu Fu, Hwan You Chang, Kuan Wang, Gwo Bin Lee

Research output: Contribution to journalArticle

38 Citations (Scopus)


Colorectal cancer (CRC) is the most frequently diagnosed cancer around the world, causing about 700,000 deaths every year. It is clear now that a small fraction of CRC, named colorectal cancer stem cells (CSCs) exhibiting self-renewal and extensive proliferative activities, are hard to be eradicated. Unfortunately, highly specific biomarkers for colorectal CSC (CR-CSCs) are lacking that prohibits the development of effective therapeutic strategies. This study designed and manufactured a novel microfluidic system capable of performing a fully automated cell-based, systematic evolution of ligands by exponential enrichment (SELEX) process. Eight CR-CSC/CRC-specific aptamers were successfully selected using the microfluidic chip. Three of the aptamers showed high affinities towards their respective target cells with a dissociation constant of 27.4, 28.5 and 12.3 nM, which are comparable to that of antibodies.

Original languageEnglish
Article number10326
JournalScientific Reports
Publication statusPublished - May 22 2015
Externally publishedYes


ASJC Scopus subject areas

  • General

Cite this